A leader of domestic pharmaceutical market, Farmak JSC has expanded its Corvalol sedative line with launching of Corvalol N Drops of mild sedative effect.
Farmak JSC has been manufacturing the original Corvalol for virtually half a century, continuously expanding the product line. Thus, in early 2013 the Company introduced to the market Corvalol tablets. In early autumn this year Corvalol N Drops (25 ml), a new product, was added to the manufacturer’s pharmaceutical products portfolio.
Oksana Stepanchuk, Marketing Consultant of Farmak OTC Product Marketing Department says, “Corvalol N Drops have mild sedative effect and reduce manifestations of stress and nervous tension. The medicine composition includes ethyl ether of α-bromoisovaleric acid, peppermint oil, and hop oil.
The medicine is recommended for neurosis with increased irritability, enterospasm, mild coronary vessel spasm, tachycardia, and complex therapy of arterial hypertension and vegetovascular dystonia”.
TOP 100. The Ratings of the Largest published the Employer Brand Rating and the Rating of TOP 30 Best HR Directors in Ukraine. According to the magazine, Farmak is one of three companies providing the best working conditions, and Viktoria Kondrashykhina, HR Director of Farmak, became the best HR director in the pharmaceutical industry. The […]
CEO of Farmak took part in a panel discussion during Kyiv Investment Forum “Local Business Development: from manufacturer to end consumer” and presented the components of successful business Paolo Di Croce, Secretary General of Slow Food International, Olha Mahaletska, Head of the Office of the National Investment Council, Iryna Danylevska, UFW Founder &...
The teams of Farmak, Alfa-Bank Ukraine, DTEK, Energoatom, FUIB, Astarta-Kyiv, EPAM, EY Ukraine, FILM.UA Group presented their projects of Integration of Sustainable Development Goals in existing business models at the final event of the international Young SDG Innovators Programme launched by the UN Global Compact. The event gathered together 148 team...